博彩导航

个人简介

王珊珊，助理研究员。曾就职于哈药集团三精制药有限公司，从事药品研发工作，获聘主管药师，具有执业药师资格。获得由国家食品药品监督管理总局组织评价，黑龙江省科学技术厅颁发的黑龙江省科学技术成果一项。目前已在Cell Discovery、Asian Journal of Pharmaceutical Sciences、Nucleic Acids Research等国际权威期刊发表学术论文10余篇。

学习和工作经历

2023.09-至今    宁波大学新药技术研究院，助理研究员

2013.07-2018.07： 哈药集团三精制药有限公司，研发专员、主管药师

2019.09-2023.06： 宁波大学 博士

2010.09-2013.07： 沈阳药科大学 硕士

2006.09-2010.07： 沈阳药科大学 学士

近年发表的主要论文

1.Wang, Shanshan, et al. "Database of space life investigations and information on spaceflight plant biology." Planta 258.3 (2023): 58.

2. Zhao, Hui, et al. "NPASS database update 2023: quantitative natural product activity and species source database for biomedical research." Nucleic Acids Research 51.D1 (2023): D621-D628.

3. Li, Fengcheng, et al. "DrugMAP: molecular atlas and pharma-information of all drugs." Nucleic acids research 51.D1 (2023): D1288-D1299.

4. Zhou, Ying, et al. "TTD: Therapeutic Target Database describing target druggability information." Nucleic Acids Research (2023): gkad751.

5.Wang, Shanshan, et al. "In silico approaches uncovering the systematic function of N-phosphorylated proteins in human cells." Computers in Biology and Medicine 151 (2022): 106280.

6.Wang, Shan-Shan, et al. "Chinese medicine meets conventional medicine in targeting COVID-19 pathophysiology, complications and comorbidities." Chinese journal of integrative medicine 28.7 (2022): 627-635.

7.Wang, Junyong, et al. "Database of space life investigations and bioinformatics of microbiology in extreme environments." Frontiers in Microbiology 13 (2022): 1017773.

8.Ma, Huabin, et al. "Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells." Cell discovery 7.1 (2021): 73.

9.Wang, Shanshan, et al. "Immunometabolism and potential targets in severe COVID-19 peripheral immune responses." Asian Journal of Pharmaceutical Sciences 16.6 (2021): 665.

10.Wang, Shanshan, et al. "East meets West in COVID-19 therapeutics." Pharmacological Research 159 (2020): 105008.

近年主持/参与的项目

略

已获授权的发明专利

略

著作编写

略

学术兼职

略